Market Assessment, Type 2 Diabetes Physician & Payer Forum South Korea and Taiwan 2014 Report

South Korea and Taiwan have the most advanced healthcare systems among Asian countries, and both operate a universal health insurance program that covers inpatient and outpatient services as well as pharmaceuticals. Both countries have a high level of pharmaceutical expenditure and an increasing awareness of the financial burden associated to type 2 diabetes which presents a significant opportunity for multinational pharmaceutical companies as the demand for novel antidiabetic drugs continues to grow. In this report, we explore the current market access environment for type 2 diabetes in both countries, and physician and payer attitudes and behaviors concerning currently marketed antidiabetic therapies, and their expectations for emerging therapies.

Back to all Market Assessment reports

Contact us

Investors

Careers

Login

Type 2 Diabetes | Physician & Payer Forum | South Korea and Taiwan | 2014

Related Market Assessment Reports

Type 1 Diabetes – Current Treatment – Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)

Type 2 Diabetes – Landscape & Forecast – Disease Landscape & Forecast

Type 1 Diabetes – Epidemiology – Epidemiology Dashboard

Type 1 Diabetes – Epidemiology – Emerging Markets

Type 1 Diabetes – Epidemiology – Asia-Pacific Data